BASF and Genomatica have expanded the scope of their license agreement for the production of 1,4-butanediol based on renewable feedstock (renewable BDO) using Genomatica’s patented process. The parties added certain countries in Southeast Asia to their initial agreement, which focused on North America.
Genomatica and Cargill have entered into a collaboration agreement to accelerate the production of renewable chemicals for industrial applications. The collaboration will give chemical producers, distributors and users access to a reliable, cost-effective source of carbohydrate feedstocks, co-location support services and production partnerships, based on GENO™ process technologies.
Genomatica, US industrial biotech company, announced that major nylon intermediates – including hexamethylenediamine, caprolactam and adipic acid (HMD, CPL and ADA) – are the focus of its third publicly-disclosed development program.
Genomatica is developing complete process technologies for the biobased production of these intermediates, which it will then license to major firms in the nylon value chain. These three chemicals, with a total market of over $18 billion per year, are used primarily in the production of nylon 6 and nylon 6,6, also referred to as the polyamides PA 6 and PA 6,6.
Braskem, the largest petrochemical producer in the Americas and the world’s leading biopolymer producer, and Genomatica, a U.S. biotechnology company, have signed an agreement for the joint development of a new technology for the production of butadiene from renewable feedstocks. Through this partnership, Braskem reaffirms its commitment to invest in the research of producing chemicals from renewable feedstocks, effectively strengthening its leadership role in this segment.
Versalis (Group Eni) and Genomatica announced the signing of a definitive joint development and licensing agreement to establish a technology joint venture for bio-based butadiene.
The two companies will work together to develop a complete ”end-to-end’ process for the production of butadiene from non-food biomass.
The resulting process will be licensed across Europe, Asia and Africa by the newly-created joint venture. Future Licensees of the process, including Versalis, will provide the capital required for the construction and operation of their own plants, and be responsible for the use and sale of the resulting butadiene.
Versalis will provide over $20 million in funding to Genomatica to support development of the integrated end-to-end process. It will also aim to be the first to license the process and build commercial plants.
IL BIOECONOMISTA 